References
- Fahy JV. Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol. 2015;15(1):57–65. doi:https://doi.org/10.1038/nri3786.
- Drick N, Seeliger B, Welte T, Fuge J, Suhling H. Anti-IL-5 therapy in patients with severe eosinophilic asthma - clinical efficacy and possible criteria for treatment response. BMC Pulm Med. 2018;18(1):119. doi:https://doi.org/10.1186/s12890-018-0689-2.
- Bousquet J, Rabe K, Humbert M, Chung KF, Berger W, Fox H, Ayre G, Chen H, Thomas K, Blogg M, et al. Predicting and evaluating response to omalizumab in patients with severe allergic asthma. Respir Med. 2007;101(7):1483–1492. doi:https://doi.org/10.1016/j.rmed.2007.01.011.
- de Nadaï P, Charbonnier A-S, Chenivesse C, Sénéchal S, Fournier C, Gilet J, Vorng H, Chang Y, Gosset P, Wallaert B, et al. Involvement of CCL18 in allergic asthma. J Immunol. 2006;176(10):6286–6293. doi:https://doi.org/10.4049/jimmunol.176.10.6286.
- Chenivesse C, Tsicopoulos A. CCL18 - Beyond chemotaxis. Cytokine. 2018;109:52–56. doi:https://doi.org/10.1016/j.cyto.2018.01.023.
- Pirayesh A, Ferdosi S, Shirzad H, Amani S, Bahadivand Chegini H, Bagheri N, Sadeghian L, Torkamand F. Differential expression of CCL18 in moderate/severe and mild persistent allergic rhinitis and its correlation with disease parameters. J Immunoassay Immunochem. 2018;39(5):485–495. doi:https://doi.org/10.1080/15321819.2018.1506931.
- Pretolani M, Soussan D, Poirier I, Thabut G, Aubier M, COBRA Study Group,. Clinical and biological characteristics of the French COBRA cohort of adult subjects with asthma. Eur Respir J. 2017;50(2):1700019. doi:https://doi.org/10.1183/13993003.00019-2017.
- Peterson S, Poposki JA, Nagarkar DR, Chustz RT, Peters AT, Suh LA, Carter R, Norton J, Harris KE, Grammer LC, et al. Increased expression of CC chemokine ligand 18 in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2012;129(1):119–127.e9. doi:https://doi.org/10.1016/j.jaci.2011.08.021.
- Yao Y, Yang C, Yi X, Xie S, Sun H. Comparative analysis of inflammatory signature profiles in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyposis. Biosci Rep. 2020;40(2). doi:https://doi.org/10.1042/BSR20193101.